| Kinetic studies and bioactivity of potential manzamine prodrugs AG Shilabin, N Kasanah, BL Tekwani, MT Hamann Journal of natural products 71 (7), 1218-1221, 2008 | 59 | 2008 |
| Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies AG Shilabin, N Kasanah, DE Wedge, MT Hamann Journal of medicinal chemistry 50 (18), 4340-4350, 2007 | 50 | 2007 |
| In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities AG Shilabin, MT Hamann Bioorganic & medicinal chemistry 19 (22), 6628-6632, 2011 | 44 | 2011 |
| Electrochemical behaviour of conducting polyfuran derivatives containing pyrrole, thiophene and ethylenic spacers AG Shilabin, AA Entezami European Polymer Journal 36 (9), 2005-2020, 2000 | 37 | 2000 |
| 2-N-Methyl modifications and SAR studies of manzamine A MA Ibrahim, AG Shilabin, S Prasanna, M Jacob, SI Khan, RJ Doerksen, ... Bioorganic & medicinal chemistry 16 (14), 6702-6706, 2008 | 31 | 2008 |
| 4-Quinolones as noncovalent inhibitors of high molecular mass penicillin-binding proteins AG Shilabin, L Dzhekieva, P Misra, B Jayaram, RF Pratt ACS Medicinal Chemistry Letters 3 (7), 592-595, 2012 | 28 | 2012 |
| 5-OHKF and NorKA, Depsipeptides from a Hawaiian Collection of Bryopsis pennata: Binding Properties for NorKA to the Human Neuropeptide Y Y1 Receptor J Gao, C Caballero-George, B Wang, KV Rao, AG Shilabin, MT Hamann Journal of natural products 72 (12), 2172-2176, 2009 | 26 | 2009 |
| On benzo [b][1, 4] diazepinium-olates,-thiolates and-carboxylates as anti-Hückel mesomeric betaines A Schmidt, AG Shilabin, M Nieger Organic & biomolecular chemistry 1 (23), 4342-4350, 2003 | 26 | 2003 |
| Photophysical properties of {[Ag (CN) 2]−} 2 complexes trapped in a supramolecular electron-acceptor organic framework JC Ahern, A Shilabin, KM Henline, RD Pike, HH Patterson Dalton Transactions 43 (31), 12044-12049, 2014 | 20 | 2014 |
| Marine Inspired 2-(5-Halo-1H-indol-3-yl)-N,N-dimethylethanamines as Modulators of Serotonin Receptors: An Example Illustrating the Power of Bromine as Part … MA Ibrahim, AT El-Alfy, K Ezel, MO Radwan, AG Shilabin, ... Marine Drugs 15 (8), 248, 2017 | 19 | 2017 |
| Synthesis and biological activity of fused tetracyclic Pyrrolo [2, 1-c][1, 4] benzodiazepines JK Annor-Gyamfi, JM Jarrett, JO Osazee, D Bialonska, C Whitted, ... Heliyon 4 (2), 2018 | 17 | 2018 |
| New derivatives and ring systems of annulated pyrrolobenzo [1, 4] diazepines A Schmidt, AS Lindner, AG Shilabin, M Nieger Tetrahedron 64 (9), 2048-2056, 2008 | 15 | 2008 |
| First in class (S,E)-11-[2-(arylmethylene)hydrazono]-PBD analogs as selective CB2 modulators targeting neurodegenerative disorders D Mingle, M Ospanov, MO Radwan, N Ashpole, M Otsuka, SA Ross, ... Medicinal Chemistry Research 30, 98-108, 2021 | 12 | 2021 |
| Pyrimidine‐Annulated Pyrrolobenzodiazepines. A New Ring System Related to Aspergillus Alkaloids A Schmidt, A Gholipour Shilabin, J Christoph Namyslo, M Nieger, ... European journal of organic chemistry 2005 (9), 1781-1789, 2005 | 12 | 2005 |
| Syntheses and Tautomerisations of Amino-substituted and Pyrimidineannulated Pyrrolobenzodiazepines A Schmidt, AG Shilabin, M Nieger Heterocycles-Sendai Institute of Heterocyclic Chemistry 65 (3), 625-632, 2005 | 12 | 2005 |
| An inhibitory compound produced by a soil isolate of Rhodococcus has strong activity against the veterinary pathogen R. equi AL Ward, P Reddyvari, R Borisova, AG Shilabin, BC Lampson PloS one 13 (12), e0209275, 2018 | 11 | 2018 |
| Seven-membered Ring Mesomeric Betaines: From Anti-Hückel Aromatics to Model Compounds of the Pyrrolobenzodiazepine Alkaloids Circumdatin A and B AG Shilabin Papierflieger, 2005 | 6 | 2005 |
| Thiazolidinone-annulated pyrrolobenzodiazepines. Syntheses and properties of a new ring system A Schmidt, AG Shilabin, M Nieger Heterocycles 63 (19), 2851-2858, 2004 | 6 | 2004 |
| Synthesis and X-ray analysis of new 1, 5-benzodiazepinium picrates A Schmidt, AG Shilabin, M Nieger Heterocycles: an international journal for reviews and communications in …, 2003 | 5 | 2003 |
| Identification of an orally bioavailable, brain-penetrant compound with selectivity for the cannabinoid type 2 receptor M Ospanov, SP Sulochana, JJ Paris, JM Rimoldi, N Ashpole, L Walker, ... Molecules 27 (2), 509, 2022 | 4 | 2022 |
